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Parkinson’s disease (PD) is a common neurodegenerative di-
sorder, being leading cause of neurological disability in indivi-
duals older than 60.  For the decades the PD was considered to
be a movement disorder defined by its motor signs. Current
understanding of PD considers PD as a multisystem brain di-
sorder in which non-motor symptoms (NMS) such as depres-
sion, cognitive impairment, autonomic and sensory symptoms
(pain) as well as sleep problems frequently occurs, having cru-
cial impact on functioning and quality of life (QoL).  Although
NMS correlate with advancing age and disease severity, some
NMS such depression, olfactory problems, constipation and
REM disorders, can occur early in the disease. These symptoms
are increasingly recognized to precede motor symptoms as the
pre-motor (pre-symptomatic) stage of PD. In our study we eva-
luated 56 consecutive de-novo PD patients (30 males, 26 fe-
males; mean age 60.9+9.1 years), H&Y stage 1-3. The most
frequent non-motor symptom was depression (45%). It was
followed by constipation (35%), unexplained pain (29%) and
sleep disturbances (23%). Depression is the most significant
predictor of QoL in PD patients.  The occurrence of depression
has been found more common in young onset PD patients des-
pite similar disease duration and lower disease severity. (Klepac
N, Relja M Cogn Behav Neurol 2008;21:87-91) Although pain
is a prominent NMS in PD it has not been well studied.
Usually it was considered that pain is of secondary causes as
musculosceletal origin. Sometimes secondary pain is relived by
levodopa indicating that it should be considered as part of spec-
trum of NMS in PD patients. The most important finding in
our study is that there is no difference of depression and co-
gnition score between patients with and without pain (Relja
M. Parkinsonism Relat Disor 2012;18S:232-235). The quan-
titative assessments of pain indicate the presence of pain in PD
patients both as prodromal sign as well as co-morbid condition
in the later stage of the disease.
In conclusion: NMS causes problems in the daily life of PD pa-
tients and have a great impact on the quality of life, but they are
usually under-diagnosed. To improve the treatment of PD pa-
tients and especially QoL, both motor as well as non-motor
symptoms should be assessed.
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